Microphysiology systems offer promising new alternatives for disease investigations and safety testing. Learn more about this leading-edge technology in our webinar featuring Lawrence Vernetti, PhD, University of Pittsburgh.

Key topics include:

• How primary human liver cells can be structurally organized in a microphysiology systems (MPS) format for superior ADMET and liver disease studies.
• A unique human liver MPS that can be progressed from a normal to non-alcoholic fatty liver disease model.
• How the liver disease MPS model recapitulates many features of clinical disease initiation and progression.